Coronary percutaneous revascularization procedures

Series
Coronary interventions
Status
Published
Date
Number of report
019

Ask the expert

(we accept only company emails)

Report presents summary of reimbursement situation for number of coronary percutaneous revascularization methods. Procedures, covered in the report include:

  • Percutaneous coronary balloon angioplasty (including plain and drug-coated balloons)
  • Percutaneous coronary angioplasty with stenting using bare metal, drug-eluting and bioresorbable stents
  • Mechanical thrombectomy
  • Mechanical atherectomy

Analysis is provided for three indications: stable angina, unstable angina and acute myocardial infarction.

Day case procedures are not considered in the report. 

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Manufacturers of devices for coronary percutaneous revascularization include:

  • Aachen Resonance (PTCA catheter CORONARY)
  • Abbott Vascular (Coronary stent XIENCE Alpine, Coronary stent XIENCE Xpedition, Coronary stent graft GRAFTMASTER RX)
  • Accura (Coronary stent Accura Decent S, Coronary stent Decent, PTCA catheter Positsoon)
  • Acrostak (PTCA catheter ACROSS HP™, PTCA catheter GRIP™)
  • amg International (Coronary stent Pico Elite Paclitaxel, Coronary stent ICROS, PTCA catheter ISTAR)
  • Amnis Therapeutics (Biological membrane-covered coronary stent AneugraftDx)
  • Andramed (Coronary stent AndraStent)
  • AngioScore (PTCA catheter AngioSculpt®)
  • Argon Medical (Fixed Core Straight & PTFE Coated Guidewires)
  • Arthesys (Coronary stent Cygnus II, PTCA catheter Maya)
  • Asahi Intecc (PTCA catheter Zenyte EX)
  • B. Braun (Coronary stent Coroflex® ISAR NEO, Coronary stent Coroflex® Blue Neo, PTCA catheter SeQuent® Please NEO, PTCA catheter SeQuent® Neo, PTCA catheter NSE Alpha, PTCA catheter SeQuent® Please OTW)
  • Balton (Coronary stent BIOSS, Coronary stent BIOSS EXPERT, PTCA catheter RIVER, PTCA catheter BOTTLE)
  • Bentley InnoMed (Coronary stent graft BeGraft)
  • Biomerics (PTCA Balloon catheters)
  • Biotronik (Coronary stent Magmaris, Coronary stent Orsiro, PTCA catheter Pantera LEO, PTCA catheter Pantera Pro)
  • Boston Scientific (Coronary stent Promus PREMIER™, Coronary stent ION™, PTCA catheter Apex™, PTCA catheter Emerge™)
  • Capture Vascular (Thrombectomy catheter MegaVac)
  • Cardionovum (Coronary stent Precision® series, Coronary stent Xlimus series)
  • Cardiva (Flagship XS. PTCA coronary guide)
  • Celonova (Coronary stent COBRA PzF™, Coronary stent CATANIA™)
  • Clearstream Technologies  (Coronary stent SatinFlex™, Coronary stent ClearFlex-X®, PTCA catheter NIMBUS PICO® µ, PTCA catheter Nimbus Salvo™)
  • Comed (Coronary stent Deimos™, Coronary stent Miranda™, PTCA catheter Oberon™)
  • Conic Vascular (PTCA balloon catheter NC CLEVER)
  • Control Medical Technology (Thrombectomy catheter ASPIRE)
  • Cordis (PTCA catheter EMPIRA®, PTCA catheter EMPIRA® NC)
  • Degania Silicone (Coronary stent, PTCA catheter)
  • Elixir Medical (Coronary stent DESyne®, Coronary stent DESyne® BD)
  • Endocor (Coronary stent SEQUENCE™, Coronary stent CONSTELLATION™, PTCA catheter CARDIOGLIDE™ HP, PTCA catheter CARDIOGLIDE™ CTO,Thrombectomy catheter PHANTOM 7F™, Thrombectomy catheter PHANTOM™ 5F)
  • Eucatech (Coronary stent eucaLimus, Coronary stent Ccflex, PTCA catheter eucaVI)
  • Eurocor (Coronary stent E-MAGIC PLUS, Coronary stent MAGICAL®, PTCA catheter DIOR)
  • Goodman Medical Ireland Limited (PTCA balloon Lacrosse, PTCA Y connector OKAY II)
  • HEXACATH (Coronary stent Titan Optimax, Coronary stent TITAN2, PTCA catheter Mistral SC, PTCA catheter Mistral NC)
  • IMeSI Italia (PTCA catheter Apollo Fluens, PTCA catheter Apollo HP)
  • InSitu Technologies (Coronary stent Celosia™, Coronary stent Direct-Stent®, Coronary stent graft Direct-Stent®, PTCA catheter Arriva™ PTCA)
  • InspireMD (Coronary stent Mguard, Coronary stent MGuard Prime)
  • Intelligent Kinetics (PEGASUS PTCA Balloon Catheter, ABARIS Rapamycin-Eluting Coronary Stent System, CORPAX Drug Eluting Balloon)
  • iVascular (Coronary stent Angiolite, Coronary stent Architect, Thrombectomy catheter Capturer, Coronary stent graft Prograft, PTCA catheter NC Xperience)
  • Japan Lifeline (PTCA Guide Wires, PTCA Balloon Catheters)
  • Kaneka (PTCA Balloon Catheter IKAZUCHI Zero, IKAZUCHI-Rev, IKAZUCHI X Hyp, RAIDEN3, Ryusei)
  • LVD Biotech (PTCA Guide wires)
  • Medas Inc (Coronary stent Inspire™, Coronary stent Brave™)
  • Medinol (Coronary stent NIRxcell™, PTCA catheter Assure™)
  • Merit Medical Systems (Catheter guidewire Worley™, Catheter guidewire Ostial PRO®)
  • Micro Science Medical AG (Paclitaxel coated Drug Eluting PTCA Balloon Catheter MSM® DECO, BMS Stainless Steel Stent Coronary Implant System MSM® CIS BARE  (Stent))
  • MicroPort (PTCA catheter FOXTROT™ NC, PTCA catheter JIVE™)
  • Minvasys (Coronary stent Nile® Pax, Coronary stent Nile Croco®, PTCA catheter Yangtze® µ, PTCA catheter Yangzte® NC)
  • Opsens (Pressure Wire OptoWire Deux)
  • Oscor (Balloon catheters, Stent delivery systems)
  • Ostial Corporation (Flash-C PTCA balloon dilatation catheters)
  • QualiMed (PTCA Balloon catheter)
  • Rontis Medical (Coronary stent Abrax™, Coronary stent Phoenix Pico™)
  • SIS Medical (PTCA catheter TIN®, PTCA catheter BEO NC®)
  • Stentys (Coronary stent Xposition S, Coronary stent MiStent SES®)
  • STI Laser (Coronary stents)
  • Svelte Medical Systems (Coronary stent SVELTE™)
  • Terumo (Coronary stent Ultimaster®, Coronary stent Kaname®, PTCA catheter Heartrail® II, PTCA catheter Accuforce®)
  • Tokai Medical Products (Jadeite PTCA balloon catheter)
  • Translumina (Coronary stent Yukon® Choice PC, Coronary stent Yukon® Choice 4DES,  PTCA catheter Cathy N° 4)
  • Tryton Medical (Coronary stent)
  • Vitalcor (CORONARY ARTERY PERFUSION CANNULA WITH BALLOON)
  • Wellinq (Coronary stent Track, Coronary stent Pioneer, PTCA catheter Protégé, PTCA catheter Protégé NC, PTCA catheter Force NC, PTCA catheter Everest)
  • Zeus (Covered Stents)

Table of content

1.    Introduction and summary
2.    Executive summary table
3.    Contents
4.    Abbreviations
5.    Methodology
6.    Reimbursement analysis in Austria

6.1.    Overview of the reimbursement system
6.2.    Reimbursement for coronary percutaneous revascularization procedures
6.2.1.    Procedure coding
6.2.2.    Diagnosis coding
6.2.3.    Payment mechanism and reimbursement tariffs
6.2.4.    Policy considerations by the LBI-HTA
7.    Reimbursement analysis in Belgium
7.1.    Overview of the reimbursement system
7.2.    Reimbursement for coronary percutaneous revascularization procedures
7.2.1.    Procedure coding
7.2.2.    Payment mechanism and reimbursement tariffs
7.2.3.    Policy considerations 
7.2.4.    Health technology assessments by KCE 
8.    Reimbursement analysis in Denmark
8.1.    Overview of the reimbursement system
8.2.    Reimbursement for coronary percutaneous revascularization procedures
8.2.1.    Procedure coding 
8.2.2.    Diagnosis coding
8.2.3.    Payment mechanism and reimbursement tariffs
8.2.4.    Policy considerations 
9.    Reimbursement analysis in England
9.1.    Overview of the reimbursement system
9.2.    Reimbursement for coronary percutaneous revascularization procedures
9.2.1.    Procedure coding 
9.2.2.    Diagnosis coding
9.2.3.    Payment mechanism and reimbursement tariffs
9.2.4.    Policy considerations 
9.2.4.1.    Specifics of commissioning of the procedure
9.2.4.2.    Health technology assessments by NICE
10.    Reimbursement analysis in France
10.1.    Overview of the reimbursement system
10.2.    Reimbursement for coronary percutaneous revascularization procedures
10.2.1.    Procedure coding 
10.2.2.    Diagnosis coding
10.2.3.    Payment mechanism and reimbursement tariffs
10.2.4.    Policy considerations by HAS
11.    Reimbursement analysis in Germany
11.1.    Overview of the reimbursement system
11.2.    Reimbursement for coronary percutaneous revascularization procedures
11.2.1.    Procedure coding 
11.2.2.    Diagnosis coding
11.2.3.    Payment mechanism and reimbursement tariffs
11.2.4.    Policy considerations by G-BA
12.    Reimbursement analysis in Italy
12.1.    Overview of the reimbursement system
12.2.    Reimbursement for coronary percutaneous revascularization procedures
12.2.1.    Procedure coding at national level
12.2.2.    Procedure coding at regional level (Emilia-Romagna, Lombardy, Veneto regions)
12.2.3.    Diagnosis coding
12.2.4.    Payment mechanism and reimbursement tariffs at national level
12.2.5.    Payment mechanism and reimbursement tariffs at regional level
13.    Reimbursement analysis in the Netherlands
13.1.    Overview of the reimbursement system
13.2.    Reimbursement for coronary percutaneous revascularization procedures
13.2.1.    Procedure coding 
13.2.2.    Diagnosis coding
13.2.3.    Payment mechanism and reimbursement tariffs
13.2.4.    Policy considerations by Dutch Healthcare Institute (СIN)
14.    Reimbursement analysis in Norway
14.1.    Overview of the reimbursement system
14.2.    Reimbursement for coronary percutaneous revascularization procedures
14.2.1.    Procedure coding 
14.2.2.    Diagnosis coding
14.2.3.    Payment mechanism and reimbursement tariffs
14.2.4.    Policy considerations 
15.    Reimbursement analysis in Sweden
15.1.    Overview of the reimbursement system
15.2.    Reimbursement for coronary percutaneous revascularization procedures
15.2.1.    Procedure coding 
15.2.2.    Diagnosis coding
15.2.3.    Payment mechanism and reimbursement tariffs
15.2.4.    Policy considerations
16.    Reimbursement analysis in Switzerland
16.1.    Overview of the reimbursement system
16.2.    Reimbursement for coronary percutaneous revascularization procedures
16.2.1.    Procedure coding 
16.2.2.    Diagnosis coding
16.2.3.    Payment mechanism and reimbursement tariffs
16.2.4.    Policy considerations
17.    Disclaimer

10

Oct 2018

EUnetHTA is a network of HTA bodies within Europe that promote the development of health technology assessment in all European countries by working together. This article will present the plans for the projects that will be published in the near future.

Read more

31

Jul 2018

Minister of Health announced that it is planned to re-equip 609 vascular surgery centers. In parallel, about 30 departments will be upgraded to the level of the regional vascular centers, which will increase their capacity. Ministry plans that these efforts will help to double number of primary coronary interventions in acute coronary syndrome in Russia.

Read more

31

May 2018

In the first half of May, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance for percutaneous balloon valvuloplasty for fetal critical aortic stenosis and three new medtech innovation briefings for patient position monitoring system for intracranial stereotactic radiosurgery, 3D/QFR imaging software to assess coronary fractional flow reserve non-invasively and point-of-care tests for diagnosing group A beta-haemolytic streptococcus (strep A) throat infection.

Read more

30

Nov 2017

A 155-page reimbursement report covers coronary angioplasty (using a plain and drug-coated balloon, bare metal, drug-eluting and bioresorbable stents), mechanical thrombectomy and atherectomy in hospital settings. The analysis covers procedure coding, payment mechanism, reimbursement tariff and policy restrictions. The report provides an overview of reimbursement situation in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden, and Switzerland.

Read more

20

Nov 2017

Annual report from the Italian Society of Interventional Cardiology (GISE) shows increasing trends in procedural volume of percutaneous coronary interventions (PCI), transcatheter aortic valve implantations (TAVI), mitral clip implantations, closure of left atrial appendage (LAA) and patent foramen ovale (PFO).

Read more

17

Oct 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in September 2017. They include knee and hip prostheses, therapeutic shoes, coronary stents, heart valves, peripheral stents, and balloons.

Read more

03

Oct 2017

New procedure codes will be created for stem cell procedures, extracorporeal techniques (including hemodialysis and CO2 removal), surgical interventions, including growth-controlling spinal correction, transposition of peripheral nerve, interventions on veins, and percutaneous image-guided procedures (including code for pressure measurement in coronary arteries and additional code for drug-eluting balloon). Classification will be enabled from January 1, 2018.

Read more

06

Sep 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2017. They include different types of stents and stent-grafts for multiple indications (coronary, peripheral vascular), mechanical thrombectomy devices for stroke, medical devices applied for treatment of ulcer of venous origin, remote monitoring for Implantable Cardioverter Defibrillator Systems (ICDS).

Read more

16

Aug 2017

In the second two weeks of July, the National Institute for Health and Care Excellence published one new (FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care) and 3 updated Medtech Innovation Briefings, new Diagnostics Guidance for quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care and three new Interventional Procedures Guidance for laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease, transcatheter aortic valve implantation for aortic stenosis and hysteroscopic sterilisation by insertion of intrafallopian implants.

Read more

03

Jul 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). They include coronary stents, portable oxygen concentrators, Urolift device, spinal ganglion stimulator and insulin pumps.

Read more
(we accept only company emails)